Ilya Petrou, MD, is a contributing writer for Dermatology Times.
Trial compares NMSC destructive techniques
October 21st 2020A recent study showed that curettage and cryotherapy, and electrodesiccation and curettage are two techniques that have comparable cure rates. The study’s findings highlight the efficacy and reliability of these treatment approaches for minimally invasive cutaneous carcinomas.
3D imaging technique measures severity of atrophic acne scars
October 11th 2020There is a dire need to improve the clinical tools dermatologists use to assess the severity of acne scars. This 3D imaging technique may help, according to a recent study presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.
A ‘biomarker’ of psychiatric adverse effects with isotretinoin?
July 17th 2020While recognizing that a patient’s mental health generally improves with isotretinoin use due to improvement in acne symptoms, clinicians may consider screening for insomnia during the course of treatment, as it may be an indicator for vulnerability to side effects, researchers say.
Researchers encourage reporting on hormone therapy in acne trial demographics
July 16th 2020Many current acne clinical trials do not consider those patients already on hormone therapy, which researchers say may affect therapeutic outcomes. Authors of a recent study encourage this reporting in future studies to help clinicians better assess how the data might represent a practice population.
Nanotechnology: An opportunity to advance skin cancer treatment
July 1st 2020In cancer immunotherapy, nanoparticles can be directed to different cells and tissues related to the immune response. This technology is currently being investigated to enhance drug delivery in skin cancer therapy with the hope of promoting more robust antitumor effects and improved clinical outcomes.
No evidence of increased cancer incidence in children using topical
June 24th 2020A recent study shows no increased risk of incidence of malignancies in patients using topical tacrolimus. A black box warning on the therapy has made it challenging for physicians to prescribe, and researchers hope this evidence will lead to the FDA reconsidering that warning.
Education at mammogram impacts skin cancer awareness
October 11th 2018Patients that schedule regular mammograms could easily be encouraged to screen for melanoma via self-skin examination when given instructions at their breast cancer screenings, according to a recent study. This type of intervention program could be an effective strategy to increase skin cancer awareness.